Following The Pharma Money

Tracking the corporate cash and weak excuses behind conservative Dems’ opposition to their party’s plan to reduce drug prices.
Following The Pharma Money
AP Photo/Rick Bowmer

Friends:

We have a double feature for you today: two major stories The Daily Poster dug out on corporate efforts to detail a proposal to lower prescription drug prices. Huge thanks to our paying subscribers for funding this work. Check out these stories:

1. Sinema Threat Followed Boost From Pharma Group: A dark money group funded by drugmakers launched ads promoting Sen. Kyrsten Sinema just before the Arizona Democrat informed the White House that she opposes the party’s plan to lower prescription drug prices as part of President Joe Biden’s $3.5 trillion infrastructure reconciliation package. Sinema’s threat to kill the legislation came despite a recent poll showing more than 80 percent of Arizonans support the Democrats’ proposal.

Click here to read the report...

2. Dems Flail Over Pharma Cash And Drug Pricing Vote: Conservative Democratic Reps. Scott Peters (Calif.) and Kurt Schrader (Ore.) have been weakly defending their huge hauls of campaign cash from the pharmaceutical industry since announcing their opposition to House Democrats’ wildly popular plan to reduce drug prices. Meanwhile, another Democratic lawmaker, Rep. Kathleen Rice (N.Y.), has completely flipped her reasoning for why she voted against the measure.

Click here to read the report...

Comments

Only paid subscribers can comment.
Please subscribe or sign in to join the conversation.